Jiangsu Hengrui Medicine
600276.SS
#479
Rank
C$60.24 B
Marketcap
$9.44
Share price
-1.54%
Change (1 day)
3.07%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$0.79 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are C$0.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$0.77 B4.96%
2021-12-31C$0.73 B-4.13%
2020-12-31C$0.77 B57.41%
2019-12-31C$0.48 B-4.43%
2018-12-31C$0.51 B26.47%
2017-12-31C$0.40 B43.79%
2016-12-31C$0.28 B15.57%
2015-12-31C$0.24 B39.4%
2014-12-31C$0.17 B76.14%
2013-12-31C$99.27 M38.32%
2012-12-31C$71.77 M0.91%
2011-12-31C$71.12 M11.81%
2010-12-31C$63.61 M23.69%
2009-12-31C$51.42 M25.34%
2008-12-31C$41.03 M-25.48%
2007-12-31C$55.05 M83.58%
2006-12-31C$29.99 M17.35%
2005-12-31C$25.55 M-31.65%
2004-12-31C$37.38 M-56.47%
2003-12-31C$85.88 M14.06%
2002-12-31C$75.29 M8.36%
2001-12-31C$69.49 M